Chronically elevated glucose compromises myocardial mitochondrial DNA integrity by alteration of mitochondrial topoisomerase function.
Mitochondrial dysfunction has a significant role in the development and complications of diabetic cardiomyopathy. Mitochondrial dysfunction and mitochondrial DNA (mtDNA) mutations are also associated with different types of cancer and neurodegenerative diseases. The goal of this study was to determine if chronically elevated glucose increase in mtDNA damage contributed to mitochondrial dysfunction and identify the underlying basis for mtDNA damage. H9c2 myotubes (a cardiac-derived cell line) were studied in the presence of 5.5, 16.5, or 33.0 mM glucose for up to 13 days. Tests of mitochondria function (Complex I and IV activity and ATP generation) were all significantly depressed by elevated media glucose. Intramitochondrial superoxide and intracellular superoxide levels were transiently increased during the experimental period. AnnexinV binding (a marker of apoptosis) was significantly increased after 7 and 13 days of high glucose. Thirteen days of elevated glucose significantly increased mtDNA damage globally and across the region encoding for the three subunits of cytochrome oxidase. Using mitochondria isolated from cells chronically exposed to elevated glucose, we observed significant increases in topoisomerase-linked DNA cleavage. Mitochondria-dependent DNA cleavage was significantly exacerbated by H(2)O(2) and that immunoprecipitation of mitochondrial extracts with a mtTOP1 antibody significantly decreased DNA cleavage, indicating that at least part of this activity could be attributed to mtTOP1. We conclude that even mild increases in glucose presentation compromised mitochondrial function as a result of a decline in mtDNA integrity. Separate from a direct impact of oxidative stress on mtDNA, ROS-induced alteration of mitochondrial topoisomerase activity exacerbated and propagated increases in mtDNA damage. These findings are significant in that the activation/inhibition state of the mitochondrial topoisomerases will have important consequences for mitochondrial DNA integrity and the well being of the myocardium.
Dept. of Physiology, New York Medical College, Valhalla, NY 10595, USA.
S
S
Medikayala
B
B
Piteo
X
X
Zhao
J G
JG
Edwards
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D017304:Annexin A5 / Q000032:analysis; D017209:Apoptosis; D002460:Cell Line; D002908:Chronic Disease; D004249:DNA Damage; D026942:DNA Topoisomerases / Q000378:metabolism*; D004272:DNA, Mitochondrial / Q000378:metabolism*; D058065:Diabetic Cardiomyopathies / Q000201:enzymology; D042967:Electron Transport Complex I / Q000378:metabolism; D003576:Electron Transport Complex IV / Q000378:metabolism; D006861:Hydrogen Peroxide / Q000378:metabolism; D006943:Hyperglycemia / Q000201:enzymology*; D008929:Mitochondria, Heart / Q000201:enzymology*; D018485:Muscle Fibers, Skeletal / Q000201:enzymology*; D009206:Myocardium / Q000201:enzymology*; D051381:Rats; D013481:Superoxides / Q000032:analysis / Q000378:metabolism; D059003:Topoisomerase Inhibitors / Q000494:pharmacology
D017304:Annexin A5; D004272:DNA, Mitochondrial; D059003:Topoisomerase Inhibitors; D013481:Superoxides; D000255:Adenosine Triphosphate; D006861:Hydrogen Peroxide; D003576:Electron Transport Complex IV; D026942:DNA Topoisomerases; D042967:Electron Transport Complex I